Compounds > 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone
Page last updated: 2024-11-03

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Adrenal Cancer

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with Adrenal Cancer in 2 studies

4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone: Inhibitor of phosphodiesterases.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, YH1
Conti, M1
Lee, YC1
Lai, HL1
Ching, YH1
Chern, Y1
Chern, YJ1
Kim, KT1
Slakey, LL1
Westhead, EW1

Other Studies

2 other studies available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Adrenal Cancer

ArticleYear
Activation of phosphodiesterase IV during desensitization of the A2A adenosine receptor-mediated cyclic AMP response in rat pheochromocytoma (PC12) cells.
    Journal of neurochemistry, 1997, Volume: 69, Issue:3

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenosine; Adre

1997
Adenosine receptors activate adenylate cyclase and enhance secretion from bovine adrenal chromaffin cells in the presence of forskolin.
    Journal of neurochemistry, 1988, Volume: 50, Issue:5

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenosine; Aden

1988